引用本文:卞俊杰,田国防.奥沙利铂与紫杉醇分别联合5-Fu在胃癌根治术后的应用效果比较[J].中国临床新医学,2017,10(2):130-133.
【打印本页】   【下载PDF全文】   查看/发表评论  【EndNote】   【RefMan】   【BibTex】
←前一篇|后一篇→ 过刊浏览    高级检索
本文已被:浏览 1898次   下载 1383 本文二维码信息
码上扫一扫!
分享到: 微信 更多
奥沙利铂与紫杉醇分别联合5-Fu在胃癌根治术后的应用效果比较
卞俊杰,田国防
453000 河南,新乡市中心医院肿瘤内一科
摘要:
[摘要] 目的 比较奥沙利铂(L-OHP)及紫杉醇(PTX)分别联合5-氟尿嘧啶(5-Fu)化疗方案在胃癌根治术后的应用效果及安全性。方法 选取2010-06~2013-05该院收治的66例胃癌根治术后患者作为研究对象,按入院顺序编号半随机分为A、B两组各33例。A组采用奥沙利铂联合5-Fu术后辅助化疗方案,B组采用紫杉醇联合5-Fu方案,均随访2年,统计肿瘤复发率、转移率、患者无瘤生存率、总生存率及毒副反应发生率。结果 A组、B组术后1年、2年肿瘤复发、转移率比较差异无统计学意义(P>0.05)。A、B组术后1年、2年无瘤生存率、总体生存率比较差异均无统计学意义(P>0.05)。A组Ⅲ~Ⅳ度中性粒细胞减少,恶心、呕吐,周围神经毒性、发热、肝功能异常发生率略高于B组,但差异无统计学意义(P>0.05)。结论 奥沙利铂与紫杉醇分别联合5-Fu在胃癌根治术后辅助化疗中均有确切疗效,患者均可耐受,安全性较高。
关键词:  奥沙利铂  紫杉醇  5-Fu  胃癌根治术  化疗
DOI:10.3969/j.issn.1674-3806.2017.02.10
分类号:R 735.2
基金项目:
Comparison of the clinical effects between oxaliplatin and paclitaxel respectively combined with 5-Fu on the treatment of gastric cancer after radical resection
BIAN Jun-jie, TIAN Guo-fang
The First Department of Internal Medicine - Oncology, Central Hospital of Xinxiang City, Henan 453000, China
Abstract:
[Abstract] Objective To compare the clinical effects and safety between oxaliplatin(L-OHP) and paclitaxel(PTX) respectively combined with 5-fluorouracil(5-Fu) chemotherapy on the patients with gastric cancer after radical resection.Methods Sixty-six patients who underwent radical resection of gastric cancer were selected as the study subjects. They were numbered in the order of admission, and were randomly divided into group A and group B, with 33 cases in each group. The group A was treated with L-OHP combined with 5-Fu adjuvant chemotherapy, while the group B was treated with PTX combined 5-Fu. Both of the two groups were followed up for 2 years. The tumor recurrence rate, metastasis rate, tumor-free survival rate, overall survival rate and incidence of toxic and side effects were compared between the two groups.Results There were no significant differences in postoperative 1-year or 2-year tumor recurrence and metastasis rate between the group A and the group B(P>0.05); There were no differences in postoperative 1-year or 2-year disease-free survival rates and overall survival rates between the group A and the group B(P>0.05); The incidences of grade Ⅲ~Ⅳ neutropenia, nausea and vomiting, peripheral nerve toxicity, fever and abnormal liver function in the group A were slightly higher than those in the group B but there were no significant differences between the two groups(P>0.05).Conclusion L-OHP and PTX respectively combined with 5-Fu in adjuvant chemotherapy are both safe and effective in the treatment of gastric cancer after radical resection.
Key words:  Oxaliplatin  Paclitaxel  5-Fu  Radical resection of gastric cancer  Chemotherapy